Clinical Trial Update: ExCrossV Multi Site Trial for Vascularized High Risk Keratoplasty [Phase 2]

View source ↗

Summary

Phase 2 multi-site clinical trial of ExCrossV for corneal transplant failure (vascularized high-risk keratoplasty) is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Transplant Failure

Drugs mentioned

• ExCrossV

Snippet

Sponsor: Massachusetts Eye and Ear Infirmary | Conditions: Corneal Transplant Failure | Phase 2 | Status: RECRUITING